What mediates the benefits associated with dipe... [Diabetologia. 2005] - PubMed

loading

Dipeptidyl peptidase inhibitors as new drugs for the treatment of type 2 diabetes. [Diabetologia. 2005]
Dipeptidyl peptidase inhibitors as new drugs for the treatment of type 2 diabetes.
Mest HJ, Mentlein R. Diabetologia. 2005 Apr; 48(4):616-20. Epub 2005 Mar 16.
Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors. [Diabetologia. 2005]
Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors.
Holst JJ, Deacon CF. Diabetologia. 2005 Apr; 48(4):612-5. Epub 2005 Mar 10.
The therapeutic actions of DPP-IV inhibition are not mediated by glucagon-like peptide-1. [Diabetologia. 2005]
The therapeutic actions of DPP-IV inhibition are not mediated by glucagon-like peptide-1.
Nauck MA, El-Ouaghlidi A. Diabetologia. 2005 Apr; 48(4):608-11. Epub 2005 Mar 11.
Review Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors. [Expert Opin Emerg Drugs. 2004]
Review Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors.
Holst JJ. Expert Opin Emerg Drugs. 2004 May; 9(1):155-66.
Review Dipeptidyl peptidase IV (DPP IV) inhibitors: A newly emerging drug class for the treatment of type 2 diabetes. [Diab Vasc Dis Res. 2006]
Review Dipeptidyl peptidase IV (DPP IV) inhibitors: A newly emerging drug class for the treatment of type 2 diabetes.
Green BD, Flatt PR, Bailey CJ. Diab Vasc Dis Res. 2006 Dec; 3(3):159-65.

Review Review of sitagliptin phosphate: a novel treatment for type 2 diabetes. [Vasc Health Risk Manag. 2007]
Review Review of sitagliptin phosphate: a novel treatment for type 2 diabetes.
Gallwitz B. Vasc Health Risk Manag. 2007; 3(2):203-10.
New therapeutic strategies for the treatment of type 2 diabetes mellitus based on incretins. [Rev Diabet Stud. 2005]
New therapeutic strategies for the treatment of type 2 diabetes mellitus based on incretins.
Gallwitz B. Rev Diabet Stud. 2005 Summer; 2(2):61-9. Epub 2005 Aug 10.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

What mediates the benefits associated with dipeptidyl peptidase-IV inhibition?
What mediates the benefits associated with dipeptidyl peptidase-IV inhibition?
Diabetologia. 2005 Apr ;48(4):605-7. Epub 2005 Mar 16 .

PubMed
Ileal angiomyolipoma as an unusual cause of small-intestinal intussusception.
Ileal angiomyolipoma as an unusual cause of small-intestinal intussusception.
J Gastroenterol. 2005 Feb ;40(2):200-3.

PubMed
Left ventricular aneurysm and prognosis in patients with first acute transmural ...
Left ventricular aneurysm and prognosis in patients with first acute transmural anterior myocardial infarction and isolated left anterior descending artery disease.
Eur Heart J. 1992 Jan ;13(1):39-44.

PubMed
Failure to detect an 8p22-8p23.1 duplication in patients with Kabuki (Niikawa-Ku...
Failure to detect an 8p22-8p23.1 duplication in patients with Kabuki (Niikawa-Kuroki) syndrome.
Eur J Hum Genet. 2005 May ;13(5):690-3.

PubMed
Correlation of radiographic parameters and clinical symptoms in adult scoliosis.
Correlation of radiographic parameters and clinical symptoms in adult scoliosis.
Spine (Phila Pa 1976). 2005 Mar 15 ;30(6):682-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed